These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15147414)
21. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr. Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology of cancer in patients with renal transplants. Davison AM Adv Nephrol Necker Hosp; 1998; 28():171-94. PubMed ID: 9889990 [No Abstract] [Full Text] [Related]
23. [Malignant neoplasms in patients subjected to renal transplantation]. de Castro MC; Ianhez LE; Saldanha LB; Chocair PR; Fonseca JA; Sabbaga E Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(2):62-6. PubMed ID: 3912935 [No Abstract] [Full Text] [Related]
25. Relationship Between Vitamin D Blood Levels and Cancer Development in Renal Transplant Patients: A Case-Control Study. Ugalde-Altamirano J; Álvarez Villegas D; Revuelta I; Coloma A; Torregrosa JV Transplant Proc; 2016 Nov; 48(9):2959-2961. PubMed ID: 27932118 [TBL] [Abstract][Full Text] [Related]
26. Cancer in patients on renal replacement therapy in Lombardy, Italy. Buccianti G; Ravasi B; Cresseri D; Maisonneuve P; Boyle P; Locatelli F Lancet; 1996 Jan; 347(8993):59-60. PubMed ID: 8531567 [No Abstract] [Full Text] [Related]
27. Malignancy after kidney transplantation. Einollahi B Ann Transplant; 2012; 17(1):145-6. PubMed ID: 22466922 [No Abstract] [Full Text] [Related]
28. Recurrence of cancer after renal transplantation. Chapman JR; Sheil AG; Disney AP Transplant Proc; 2001; 33(1-2):1830-1. PubMed ID: 11267531 [No Abstract] [Full Text] [Related]
29. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160 [No Abstract] [Full Text] [Related]
30. Patterns of malignancies following renal transplantation. Sheil AG Transplant Proc; 1999; 31(1-2):1263-5. PubMed ID: 10083563 [No Abstract] [Full Text] [Related]
31. Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Brunner FP; Landais P; Selwood NH Nephrol Dial Transplant; 1995; 10 Suppl 1():74-80. PubMed ID: 7617285 [TBL] [Abstract][Full Text] [Related]
32. [Neoplasms following kidney transplantation]. Beleva B Khirurgiia (Sofiia); 1991; 44(1):38-41. PubMed ID: 1942901 [TBL] [Abstract][Full Text] [Related]
33. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677 [TBL] [Abstract][Full Text] [Related]
39. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period. Frei U; Bode U; Repp H; Schindler R; Brunkhorst R; Vogt P; Hauss J; Pichlmayr R Transplant Proc; 1993 Feb; 25(1 Pt 2):1394-6. PubMed ID: 8442152 [No Abstract] [Full Text] [Related]
40. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Sheil AG; Disney AP; Mathew TH; Livingston BE; Keogh AM Transplant Proc; 1997; 29(1-2):825-7. PubMed ID: 9123543 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]